Technical Analysis for ABMD - ABIOMED, Inc.

Grade Last Price % Change Price Change
grade A 439.64 -0.79% -3.51
ABMD closed down 0.79 percent on Tuesday, June 19, 2018, on 1.11 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical ABMD trend table...

Date Alert Name Type % Chg
Jun 19 Slingshot Bullish Bullish Swing Setup 0.00%
Jun 19 NR7 Range Contraction 0.00%
Jun 19 Overbought Stochastic Strength 0.00%
Jun 18 Spinning Top Other -0.79%
Jun 18 New 52 Week High Strength -0.79%
Jun 18 Upper Bollinger Band Walk Strength -0.79%
Jun 18 Overbought Stochastic Strength -0.79%
Jun 15 New 52 Week Closing High Bullish -0.89%
Jun 15 New 52 Week High Strength -0.89%
Jun 15 Upper Bollinger Band Walk Strength -0.89%

Older signals for ABMD ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP, a micro heart pump; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the Impella RP, a percutaneous catheter-based axial flow pump; and AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it offers Symphony, a synchronized minimally invasive implantable cardiac assist device designed to treat chronic patients with moderate heart failure by improving patient hemodynamics; and AbioCor implantable replacement heart. The company sells its products through direct sales and clinical support personnel in the United States, Canada, Germany, France, the United Kingdom, and internationally. ABIOMED, Inc. was founded in 1981 and is headquartered in Danvers, Massachusetts.
Is ABMD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 446.81
52 Week Low 139.49
Average Volume 883,493
200-Day Moving Average 250.9244
50-Day Moving Average 361.678
20-Day Moving Average 410.3145
10-Day Moving Average 427.481
Average True Range 12.0288
ADX 40.67
+DI 31.67
-DI 12.86
Chandelier Exit (Long, 3 ATRs ) 410.7236
Chandelier Exit (Short, 3 ATRs ) 411.0864
Upper Bollinger Band 451.5645
Lower Bollinger Band 369.0645
Percent B (%b) 0.86
BandWidth 20.106528
MACD Line 22.5025
MACD Signal Line 21.3996
MACD Histogram 1.1029
Fundamentals Value
Market Cap 19.4 Billion
Num Shares 44.1 Million
EPS 1.71
Price-to-Earnings (P/E) Ratio 257.10
Price-to-Sales 16.68
Price-to-Book 13.96
PEG Ratio 2.75
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 454.12
Resistance 3 (R3) 453.19 447.43 451.70
Resistance 2 (R2) 447.43 443.75 447.90 450.90
Resistance 1 (R1) 443.54 441.47 445.49 444.47 450.09
Pivot Point 437.78 437.78 438.76 438.25 437.78
Support 1 (S1) 433.89 434.10 435.84 434.82 429.19
Support 2 (S2) 428.13 431.82 428.60 428.38
Support 3 (S3) 424.24 428.13 427.58
Support 4 (S4) 425.17